
The Thiazolidinedione Controversy in Cardiovascular Risk
Author(s) -
Liebson Philip R.
Publication year - 2010
Publication title -
preventive cardiology
Language(s) - English
Resource type - Journals
eISSN - 1751-7141
pISSN - 1520-037X
DOI - 10.1111/j.1751-7141.2010.00082.x
Subject(s) - rosiglitazone , medicine , troglitazone , thiazolidinedione , pioglitazone , glycated hemoglobin , diabetes mellitus , adverse effect , pharmacology , drug , endocrinology , type 2 diabetes , peroxisome proliferator activated receptor , receptor